Bayer increases production of anthrax antibiotic Cipro

The antibiotic Cipro has gone from relative obscurity to part of America’s new vocabulary in less than two weeks.

The antibiotic Cipro has gone from relative obscurity to part of America’s new vocabulary in less than two weeks.

Just 14 months since Bayer became the only company to receive Food and Drug Administration approval to produce the anthrax antibiotic, demand is exploding.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited